Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee B Rivera

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Disease Models & Mechanisms|July 10, 2010
Rgs16 and Rgs8 in embryonic endocrine pancreas and mouse models of diabetesAlethia Villasenor, Zhao V Wang, Lee B Rivera, et al.
NMR in Biomedicine|September 10, 2014
HR-MAS MRS of the pancreas reveals reduced lipid and elevated lactate and taurine associated with early pancreatic cancerAlan S Wang, Alessia Lodi, Lee B Rivera, et al.
Cancer Research|December 19, 2013
Collagen signaling enhances tumor progression after anti-VEGF therapy in a murine model of pancreatic ductal adenocarcinomaKristina Y Aguilera, Lee B Rivera, Hoon Hur, et al.
Cancer Research|July 13, 2012
TGF-β and αvβ6 integrin act in a common pathway to suppress pancreatic cancer progressionAram F Hezel, Vikram Deshpande, Stephanie M Zimmerman, et al.
Cancer Research|July 26, 2014
Neutralizing murine TGFβR2 promotes a differentiated tumor cell phenotype and inhibits pancreatic cancer metastasisKatherine T Ostapoff, Bercin Kutluk Cenik, Miao Wang, et al.
Disease Models & Mechanisms|December 17, 2009
Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinomaShanna A Arnold, Lee B Rivera, Andrew F Miller, et al.
Science Signaling|December 9, 2025
The scavenger receptor MARCO is a ligand for the immune inhibitory receptor LAIR-1 and regulates its function in cisAkashdip Singh, Saskia V Vijver, Hajar Aglmous-Talibi, et al.
Molecular Cancer Therapeutics|April 22, 2024
Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid TumorsBertha L Rodriguez, Jiawei Huang, Laura Gibson, et al.
Cancer Immunology Research|August 24, 2021
The Fibronectin-ILT3 Interaction Functions as a Stromal Checkpoint that Suppresses Myeloid CellsKevin J Paavola, Julie M Roda, Vicky Y Lin, et al.
Cancer Immunology Research|February 23, 2024
ILT2 and ILT4 Drive Myeloid Suppression via Both Overlapping and Distinct MechanismsJane Tian, Amir M Ashique, Sabrina Weeks, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Disease Models & Mechanisms|July 10, 2010
Rgs16 and Rgs8 in embryonic endocrine pancreas and mouse models of diabetesAlethia Villasenor, Zhao V Wang, Lee B Rivera, et al.
NMR in Biomedicine|September 10, 2014
HR-MAS MRS of the pancreas reveals reduced lipid and elevated lactate and taurine associated with early pancreatic cancerAlan S Wang, Alessia Lodi, Lee B Rivera, et al.
Cancer Research|December 19, 2013
Collagen signaling enhances tumor progression after anti-VEGF therapy in a murine model of pancreatic ductal adenocarcinomaKristina Y Aguilera, Lee B Rivera, Hoon Hur, et al.
Cancer Research|July 13, 2012
TGF-β and αvβ6 integrin act in a common pathway to suppress pancreatic cancer progressionAram F Hezel, Vikram Deshpande, Stephanie M Zimmerman, et al.
Cancer Research|July 26, 2014
Neutralizing murine TGFβR2 promotes a differentiated tumor cell phenotype and inhibits pancreatic cancer metastasisKatherine T Ostapoff, Bercin Kutluk Cenik, Miao Wang, et al.
Disease Models & Mechanisms|December 17, 2009
Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinomaShanna A Arnold, Lee B Rivera, Andrew F Miller, et al.
Science Signaling|December 9, 2025
The scavenger receptor MARCO is a ligand for the immune inhibitory receptor LAIR-1 and regulates its function in cisAkashdip Singh, Saskia V Vijver, Hajar Aglmous-Talibi, et al.
Molecular Cancer Therapeutics|April 22, 2024
Antitumor Activity of a Novel LAIR1 Antagonist in Combination with Anti-PD1 to Treat Collagen-Rich Solid TumorsBertha L Rodriguez, Jiawei Huang, Laura Gibson, et al.
Cancer Immunology Research|August 24, 2021
The Fibronectin-ILT3 Interaction Functions as a Stromal Checkpoint that Suppresses Myeloid CellsKevin J Paavola, Julie M Roda, Vicky Y Lin, et al.
Cancer Immunology Research|February 23, 2024
ILT2 and ILT4 Drive Myeloid Suppression via Both Overlapping and Distinct MechanismsJane Tian, Amir M Ashique, Sabrina Weeks, et al.
Pageof 2